Download cochrane reviews in inflammatory bowel

Cochrane Database of Systematic reviews Psychological interventions for treatment of inflammatory bowel disease Information DOI: DOI Database: Cochrane Database of Systematic Reviews Version published: 15 February 2011see what's new Type: Intervention Stage: Review Cochrane Editorial Group: Cochrane Gut Group Copyright: Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Article metrics Full text views: 2818 Altmetric: Cited by: Cited 0 times via Crossref Cited-by Linking Collapse Antje Timmer Correspondence to: Clinical Epidemiology, Bremen Institute for Prevention Research and Social Medicine, Bremen, Germany [email protected] Jan C Preiss Med. Klinik I, Charité ‐ Universitätsmedizin Berlin, Berlin, Germany Edith Motschall German Cochrane Centre, Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Freiburg, Germany Gerta Rücker German Cochrane Centre, Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Freiburg, Germany Günther Jantscheka Universitätsklinikum Schleswig‐Holstein, Campus Lübeck, Lubeck, Germany Deceased Gabriele Moser Clinic of Internal Medicine III, Medical University of Vienna, A‐1090 Vienna, Austria Antje Timmer conceived the study, wrote the protocol (and a successful funding proposal), participated in devising the search strategy, screened the literature, selected the studies, extracted the data, did the quality assessments of included papers, analysed the data and wrote the manuscript. Jan Preiss screened the literature, did the hand search, selected the studies, extracted the data and did the quality assessments of included papers. Edith Motschall devised the search strategy, performed the electronic searches and wrote the methods section (search strategy). Gerta Rücker was the consulting statistician, participated in writing the protocol and review methods sections, and performed the statistical tests on small study bias. Günther Jantschek served as consulting expert (psychosomatic gastroenterology), wrote the introduction section of the protocol and consulted on the writing of the manuscript. Gabriele Moser was the consulting expert (psychosomatic gastroenterology), wrote the introduction section

Provided support for the IBD/FBD Review Group through the Olive Stewart Fund. Published Title Stage Authors Version 2011 Feb 15 Psychological interventions for treatment of inflammatory bowel disease Review Antje Timmer, Jan C Preiss, Edith Motschall, Gerta Rücker, Günther Jantschek, Gabriele Moser 2008 Jan 23 Psychological interventions for treatment of inflammatory bowel disease Protocol Antje Timmer, Guenther Jantschek, Gabriele Moser, Edith Motschall, Jan C Preiss, Gerta Rücker Inclusion criteria: non randomised trials (NRCT) were also included as distinction between random, quasi‐random and convenience based could often not be made on accounts of the reports alone. Quasi‐random and convenience procedures are common for psychological intervention trials. Of note this was in the original version of the protocol but was changed due to reviewer suggestions. The current criteria form a compromise between our original plan (which included also prospectively controlled observational studies) and the reviewers' wish (RCT only). Assessment of study quality and examination of heterogeneity were modified to better adhere to the recommendations by the Cochrane Collaboration published with RevMan 5, and recent criticism on preset criteria for I2 values. Grade C quality papers were not excluded as policies on quality/bias assessment have changed in the Cochrane Collaboration. Also, all papers were C quality. This is reflected by the Summary of Bias tables. Handsearch: As abstracts of the major conferences to be included in the handsearch are included in the specialized IBD registry, handsearching for relevant conference abstracts was restricted to conferences taking place between fall 2008 and May 2010. Screening of conference abstracts up to 2008 (summer) was done based on the special registry. Time of follow up ‐ due to the diversity of study length and variability between, and at times, within studies, 12 months assessment comprised follow up assessments between 9 and 18 months, and 6 month assessment

The American Journal of Gastroenterology. “It is well recognized that the adequacy of bowel preparation is essential for optimal colonoscopy performance.”The authors added: “To date, there is no single accepted approach to this basic element of procedural preparation. For example, there are many options for colonic lavage with important variables including effectiveness, safety, palatability and cost. Similarly, there is no standard nomenclature for discussing bowel preparation, with terms such as ‘bowel preparation’ used at times to describe the process, the regimen or the quality of bowel preparation.”To address considerable issues related to bowel preparation for colonoscopy among outpatients at low risk for inadequate bowel preparation, Jacobson and colleagues evaluated a series of clinically relevant questions, developed by experts with a clinical practice and research focus in colonoscopy and bowel preparation.They then developed 21 population-intervention-comparator-outcomes questions, which were investigated through a comprehensive literature search of EMBASE, PubMed, Cochrane Reviews and the Cochrane Central Register of Controlled Clinical Trials from January 2013 through September 2023.Jacobson and colleagues ultimately developed the original 21 PICO questions into a set of 25 recommendations intended to bolster bowel preparation prior to, during and following colonoscopy. Highlights include: The task force strongly recommends that patients undergoing colonoscopy receive both verbal and written patient education instructions for all components of the colonoscopy preparation. The task force strongly recommends limiting any dietary modifications to the day prior to colonoscopy for ambulatory patients at low risk for inadequate bowel preparation. When using a split-dose preparation for ambulatory patients at low

It is advisable to inform the Clinical Coordinator. During hospitalization the Center's team maintain regular contact with the hospital staff regarding methods of diagnosis and treatment.Back to TopPsychological ServicesWhen the medical evaluation of a patient visiting the Inflammatory Bowel Disease Center suggests that psychological evaluation would be beneficial, Psychological treatments include pain management, stress management, cognitive-behavioral therapy (CBT), relaxation training Nutrition To assist patients whose IBD has caused malnourishment, as well as those who simply wish advice on their eating habits, our registered dietician can provide important guidance on diet and nutritional aids.Patient EducationOur nurse practitioner provides valuable patient education on ways of managing IBD in daily life, and also coordinates care for patients seeing multiple specialists within the medical center.Clinical Trials and InvestigationsThe IBD Center performs clinical trials (research studies) to find new and more effective treatments for the various forms of intestinal disease. Most medications and medical techniques that are currently used have been tested in extensive clinical trials before becoming available to the public. Patients with IBD may have an opportunity to participate in a various clinical trials that are being conducted at the IBD Center. The ability to participate in such trials depends on the eligibility requirements for the study, the patient's condition and what stage the trial is at.If you are interested in participating in one or more studies, You may call or email the study coordinator for the specific study or studies you are interested in. It may be possible for you to enroll in more than one study at the same time.Back to TopFrequently Asked Questions What is inflammatory bowel disease? What is the difference between IBD and IBS? What is the difference between Crohn's disease and ulcerative colitis? Does what I eat matter? Is IBD a genetically inherited disease?What is inflammatory bowel disease?Inflammatory bowel disease (IBD) is an umbrella term referring to certain chronic diseases that cause inflammation of the intestines. Crohn's disease and ulcerative colitis are the two terms most often assigned to the different types of IBD. Although they are different diseases with a variety of forms, each disease causes the destruction of the digestive system, producing a similar group of life-altering symptoms.Back to QuestionsWhat is the difference between IBD and IBS?Inflammatory bowel disease (IBD) is easily confused with another condition known as irritable bowel syndrome (IBS). As much as 25% of the population in the United States report symptoms of IBS, and up to 50% of patients seen by gastroenterologists have symptoms of IBS.IBD and IBS have similar symptoms, particularly cramping and diarrhea, but the underlying disease process is quite different. IBD is inflammation or destruction of the bowel wall, which can lead to deep ulcerations (sores) and narrowing